The ras oncogene plays an important role in the multistep progression
to cancer by activation of signal transduction pathways that contribut
e to aberrant growth regulation. Although many of these effects are ce
ll autonomous, the ras oncogene also regulates the expression of genes
that alter host/tumor interactions. We now extend the mechanisms thro
ugh which ras promotes tumor survival by demonstrating that oncogenic
Ras inhibits expression of the fas gene and renders Ras-transformed ce
lls resistant to Fas-induced apoptosis. A panel of Ras-transformed clo
nes exhibited a marked inhibition in fas mRNA and Fas cell surface exp
ression as compared with untransformed parental cell lines. Fas expres
sion was induced by culture in the presence of IFN-gamma + tumor necro
sis factor or; however, the maximal level attained in Ras transformant
s was similar to 10-fold below the level of untransformed cells. Where
as untransformed cells were sensitive to apoptotic death induced by cr
oss-linking surface Fas (especially after cytokine treatment), pas-tra
nsformed cells were very resistant to Fas-induced death even under the
most stringent assay conditions. To demonstrate that this resistance
was mediated by oncogenic Ras and not secondary genetic events, pools
of Ras-transformed cells were generated using a highly efficient retro
viral transduction technique. Transformed pools were assayed 6 days af
ter infection and demonstrated a marked decrease in fas gene expressio
n and Fas-mediated apoptosis, Oncogenic pas did not promote general re
sistance to apoptosis, because ectopic expression of a fas cDNA in Ras
-transformed cells restored sensitivity to Fas-induced apoptosis. Thes
e data indicate that oncogenic Ras inhibits basal levels of expression
of the fas gene, and although cytokine signal transduction pathways a
re functional in these cells, the level of surface Fas expression rema
ins below the threshold required for induction of apoptosis, These dat
a identify a mechanism by which Ras-transformed cells may escape from
host-mediated immune destruction.